SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000892569-04-000204
Filing Date
2004-02-20
Accepted
2004-02-20 17:18:28
Documents
4
Period of Report
2004-02-19
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a96720e8vk.htm 8-K 13435
3 EXHIBIT 1.1 a96720exv1w1.htm EX-1.1 123400
4 EXHIBIT 5.1 a96720exv5w1.htm EX-5.1 7272
5 EXHIBIT 99.1 a96720exv99w1.htm EX-99.1 2629
  Complete submission text file 0000892569-04-000204.txt   148646
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 04619995
SIC: 2836 Biological Products, (No Diagnostic Substances)